Untitled and Anonymous Editorials And Other Forms of Provincialism

For several decades Current Contents was the vehicle I used for personal expressions of pleasure or discontent about various practices in science and scholarship. Remarkably, even after decades in some cases, not much has changed since I first voiced an opinion on subjects such as anonymity.1 One of my pet grievances with scientific and other publications has been the implied use of the editorial "we" and its expression in the form of anonymous editorials. Whether in Nature or the New York Tim

Written byEugene Garfield
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

For several decades Current Contents was the vehicle I used for personal expressions of pleasure or discontent about various practices in science and scholarship. Remarkably, even after decades in some cases, not much has changed since I first voiced an opinion on subjects such as anonymity.1

One of my pet grievances with scientific and other publications has been the implied use of the editorial "we" and its expression in the form of anonymous editorials. Whether in Nature or the New York Times we all know that an individual wrote those unsigned comments. But especially in the British science press--for example, the New Scientist-- the unsigned, anonymous editorial is used to add authority to the views expressed. Indeed, I cringe whenever one of our own staff writers or freelancers says that so and so "told The Scientist" this or that. Give me a break. He told the reporter--someone with a name. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies